Further, we examined GSTZ1 expression in 16 paired clinical HCC and normal liver tissue samples via IHC and Western blotting, which revealed that GSTZ1 was significantly downregulated in HCC rather than tumor-adjacent normal tissue (Fig. 1d-e). This evidence concerns the gene GSTZ1 and hepatocellular carcinoma.